Discover 1,425 paid clinical trials in Bradenton, Florida. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,425
A Study of Belantamab Mafodotin Administered in Combination With Lenalidomide and Dexamethasone (BRd) Versus Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With Newly Diagnosed Multiple Myeloma (NDMM) Who Are Ineligible for Autologous Stem Cell Transplantation (TI-NDMM)
Location: Englewood FL, Lady Lake FL, Pembroke Pines FL,
Sponsor: GlaxoSmithKline
Sex: All
Age: 18+
Code: NCT06679101
Phase 3, Recruiting
INNOVEN: Efficacy of Porcine Placental Extracellular Matrix Plus Standard of Care (SOC) Versus SOC Alone
for
Wound Heal, Venous Leg Ulcer
Location: North Port FL
Sponsor: ConvaTec Inc.
Sex: All
Age: 21+
Code: NCT06606210
Recruiting
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
for
Breast Neoplasms, Neoplasm Metastasis
Location: Tampa FL, Fort Myers FL, Clermont FL, Orange City FL,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT07174336
Phase 3, Recruiting
Phase 1/2 Study of Linvoseltamab in Adult Patients With Relapsed or Refractory Multiple Myeloma
for
Multiple Myeloma
Location: Tampa FL, Atlanta GA, Louisville KY, Columbus OH,
Sponsor: Regeneron Pharmaceuticals
Sex: All
Age: 18+
Code: NCT03761108
Phase 1, Phase 2, Recruiting
BGB-43395 Plus Letrozole Versus CDK4/6i Plus Letrozole for Patients With Advanced or Metastatic HR+/HER2- Breast Cancer Who Have Not Received Prior Treatment for Advanced or Metastatic Disease
for
HR+/HER2- Breast Cancer
Location: Tampa FL, Palm Bay FL, Orange City FL,
Sponsor: BeOne Medicines
Sex: All
Age: 18+
Code: NCT07492641
Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Lanreotide Versus Placebo Before Surgery to Prevent a Surgical Complication Called a Pancreatic Fistula
for
Pancreatic Carcinoma, Pancreatic Neoplasm
Location: Tampa FL, Lexington KY, Richmond VA,
Sponsor: SWOG Cancer Research Network
Sex: All
Age: 18+
Code: NCT06807437
Phase 3, Recruiting
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
for
Cutaneous Melanoma, Stage II
Location: Tampa FL, Lakeland FL, Coral Springs FL,
Sponsor: Melanoma and Skin Cancer Trials Limited
Sex: All
Age: 18+
Code: NCT03860883
Recruiting
A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
for
Breast Cancer
Location: Tampa FL, Weston FL, Jacksonville FL, Tallahassee FL,
Sponsor: Hoffmann-La Roche
Sex: All
Age: 18+
Code: NCT06790693
Phase 3, Recruiting
A Trial to Find Out if REGN5678 (Nezastomig) is Safe and How Well it Works Alone or in Combination With Cemiplimab for Adult Participants With Metastatic Castration-Resistant Prostate Cancer and Other Tumors
for
Metastatic Castration-Resistant Prostate Cancer (mCRPC),
Location: Tampa FL, Jacksonville FL, Charlottesville VA,
Sponsor: Regeneron Pharmaceuticals
Sex: All
Age: 18+
Code: NCT03972657
Phase 1, Phase 2, Recruiting
A Post-Authorisation Safety Study (PASS) of Patients Treated With Lonapegsomatropin
for
Growth Hormone Deficiency
Location: Tampa FL, Orlando FL, Sandy Springs GA, Columbia SC,
Study to Evaluate Safety, Efficacy and Pharmacokinetics (PK) of a Modified Regimen of Ublituximab
for
Relapsing Multiple Sclerosis
Location: Tampa FL, Savannah GA, Atlanta GA, Birmingham AL,
Sponsor: TG Therapeutics, Inc.
Sex: All
Age: 18 - 65
Code: NCT05877963
Phase 3, Recruiting
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
for
Renal Cell Carcinoma (RCC),
Location: Tampa FL, Celebration FL, Gainesville FL, Miami FL,
Sponsor: Exelixis
Sex: All
Age: 18+
Code: NCT05176483
Phase 1, Recruiting
A Study of IDRX-42 (GSK6042981) Versus (vs) Sunitinib in Participants With Gastrointestinal Stromal Tumors After Imatinib Therapy
for
Gastrointestinal Neoplasms
Location: Tampa FL, Orlando FL, Miami FL, Jacksonville FL,
Sponsor: GlaxoSmithKline
Sex: All
Age: 18+
Code: NCT07218926
Phase 3, Recruiting
A Study on the Immune Response and Safety of an Investigational Chickenpox Vaccine and a Marketed Measles, Mumps and Rubella Vaccine When Administered as Intramuscular Injection to Healthy Children 12 to 15 Months of Age
for
Chickenpox
Location: Tampa FL, Miami Lakes FL, Coral Gables FL, Richmond VA,
Sponsor: GlaxoSmithKline
Sex: All
Age: 1
Code: NCT06855160
Phase 3, Recruiting
Study of Orally Administered MOMA-341 in Participants With Advanced or Metastatic Solid Tumors
for
Advanced Solid Tumor, Metastatic Solid Tumor,
Location: Tampa FL, Raleigh NC, Houston TX, St Louis MO,
Sponsor: MOMA Therapeutics
Sex: All
Age: 18+
Code: NCT06974110
Phase 1, Recruiting
A Dose Escalation Phase I Study to Assess the Safety and Clinical Activity of Multiple Cancer Indications
for
Acute Myeloid Leukemia/Myelodysplastic Syndrome,
Location: Tampa FL, Buffalo NY
Sponsor: Celyad Oncology SA
Sex: All
Age: 18+
Code: NCT03018405
Phase 1, Phase 2, Recruiting
A Study of XB628 Alone and in Combination With Zanzalintinib in Participants With Recurrent Advanced or Metastatic Solid Tumors
Location: Tampa FL, Hickory NC, Nashville TN, Houston TX,
Sponsor: Exelixis
Sex: All
Age: 18+
Code: NCT06952010
Phase 1, Recruiting
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations